Functionally gene-linked polymorphic regions and genetically controlled neurotransmitters metabolism
- 3 November 2001
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 11 (6) , 431-439
- https://doi.org/10.1016/s0924-977x(01)00120-1
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Initial sequencing and analysis of the human genomeNature, 2001
- Allelic Variation in the Serotonin Transporter Promoter Affects Onset of Paroxetine Treatment Response in Late-Life DepressionNeuropsychopharmacology, 2000
- COMT andDRD3 polymorphisms, environmental exposures, and personality traits related to common mental disordersAmerican Journal of Medical Genetics, 2000
- Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?Clinical Genetics, 1999
- Post-transcriptional gene regulatory mechanisms in eukaryotes: an overviewJournal of Endocrinology, 1998
- Neuroleptic malignant syndrome and hydroxylase gene mutationsPsychiatric Genetics, 1997
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Allelic Variation of Human Serotonin Transporter Gene ExpressionJournal of Neurochemistry, 1996
- Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patientsAmerican Journal of Medical Genetics, 1995
- Late‐Onset psychosis in the velo‐cardio‐facial syndromeAmerican Journal of Medical Genetics, 1992